Genus PIC is a leading global provider of swine genetics, focusing on breeding pigs with superior traits for pork production. Research and development activities include genetic selection, genomic technologies, and advanced breeding techniques to improve traits such as growth rate, feed efficiency, and meat quality. PIC utilizes technologies like artificial insemination and embryo transfer to disseminate superior genetics. The segment's primary therapeutic area is pork production, aiming to enhance the efficiency and sustainability of the pork industry. PIC's impact is seen in improved pig performance, reduced environmental impact, and increased profitability for farmers. PIC holds a strong market position due to its advanced genetics and global presence. Future opportunities include expanding into new markets and developing disease-resistant pig breeds. Regulatory aspects involve compliance with animal welfare standards and food safety regulations. PIC collaborates with research institutions and industry partners to advance its breeding programs.

Genus ABS is a global bovine genetics business, specializing in the sale of dairy and beef bull semen and embryos. The segment's research and development efforts focus on improving traits such as milk yield, fertility, and disease resistance in cattle. ABS employs advanced technologies like genomics, artificial insemination, and embryo transfer to enhance breeding programs. The primary application is in dairy and beef production, aiming to improve the efficiency and sustainability of livestock farming. The impact of ABS's work is seen in increased milk and beef production, improved animal health, and reduced environmental impact. ABS holds a strong market position due to its superior genetics and global distribution network. Future opportunities include expanding into emerging markets and developing climate-resilient cattle breeds. Regulatory aspects involve compliance with animal health regulations and food safety standards. ABS collaborates with research institutions and industry partners to advance its breeding programs and provide innovative solutions to farmers worldwide.

Genus Research and Development (R&D) is the innovation engine of Genus plc, focused on pioneering advancements in animal genetics and biotechnology. R&D activities encompass a wide range of projects, including gene editing, genomic selection, and advanced reproductive technologies. The team utilizes cutting-edge technologies such as CRISPR, bioinformatics, and data analytics to accelerate genetic improvement. The primary focus is on developing solutions for the pork and dairy industries, with the goal of enhancing animal health, productivity, and sustainability. The impact of R&D is seen in the development of disease-resistant animals, improved feed efficiency, and enhanced meat and milk quality. Genus R&D holds a competitive advantage through its strong intellectual property portfolio and strategic collaborations. Future opportunities include expanding into new areas of animal health and developing novel breeding technologies. Regulatory aspects involve compliance with ethical guidelines and safety regulations. Genus R&D actively collaborates with universities, research institutions, and industry partners to drive innovation and translate scientific discoveries into practical applications.